285 related articles for article (PubMed ID: 8224760)
1. Vitamin D receptors in a naturally vitamin D-deficient subterranean mammal, the naked mole rat (Heterocephalus glaber): biochemical characterization.
Sergeev IN; Buffenstein R; Pettifor JM
Gen Comp Endocrinol; 1993 Jun; 90(3):338-45. PubMed ID: 8224760
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D hydroxylases and their regulation in a naturally vitamin D-deficient subterranean mammal, the naked mole rat (Heterocephalus glaber).
Buffenstein R; Sergeev IN; Pettifor JM
J Endocrinol; 1993 Jul; 138(1):59-64. PubMed ID: 7852893
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
Roy S; Martel J; Tenenhouse HS
J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
[TBL] [Abstract][Full Text] [Related]
5. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
[TBL] [Abstract][Full Text] [Related]
7. Variable in vivo regulation of rat vitamin D-dependent genes (osteopontin, Ca,Mg-adenosine triphosphatase, and 25-hydroxyvitamin D3 24-hydroxylase): implications for differing mechanisms of regulation and involvement of multiple factors.
Matkovits T; Christakos S
Endocrinology; 1995 Sep; 136(9):3971-82. PubMed ID: 7649106
[TBL] [Abstract][Full Text] [Related]
8. Age-related alteration of vitamin D metabolism in response to low-phosphate diet in rats.
Chau TS; Lai WP; Cheung PY; Favus MJ; Wong MS
Br J Nutr; 2005 Mar; 93(3):299-307. PubMed ID: 15877868
[TBL] [Abstract][Full Text] [Related]
9. Regulation of renal vitamin D receptor is an important determinant of 1alpha,25-dihydroxyvitamin D(3) levels in vivo.
Beckman MJ; DeLuca HF
Arch Biochem Biophys; 2002 May; 401(1):44-52. PubMed ID: 12054486
[TBL] [Abstract][Full Text] [Related]
10. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.
Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP
Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474
[TBL] [Abstract][Full Text] [Related]
11. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1α,25-dihydroxyvitamin D₃.
Wang Y; Zhu J; DeLuca HF
Am J Physiol Endocrinol Metab; 2015 Feb; 308(3):E201-5. PubMed ID: 25425001
[TBL] [Abstract][Full Text] [Related]
13. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
[TBL] [Abstract][Full Text] [Related]
14. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.
Hedlund TE; Moffatt KA; Miller GJ
Endocrinology; 1996 May; 137(5):1554-61. PubMed ID: 8612485
[TBL] [Abstract][Full Text] [Related]
15. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
[TBL] [Abstract][Full Text] [Related]
16. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of vitamin D: current status.
DeLuca HF
Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
[TBL] [Abstract][Full Text] [Related]
18. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria.
Zerwekh JE; Reed BY; Heller HJ; González GB; Haussler MR; Pak CY
Miner Electrolyte Metab; 1998; 24(5):307-13. PubMed ID: 9705566
[TBL] [Abstract][Full Text] [Related]
19. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
20. Autocrine control of vitamin D metabolism in synovial cells from arthritic patients.
Smith SJ; Hayes ME; Selby PL; Mawer EB
Ann Rheum Dis; 1999 Jun; 58(6):372-8. PubMed ID: 10340962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
